{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-007271","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.326764+00:00","generated_at":"2026-06-18T05:38:51.919997+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Intelligent Bio Solutions closes $2.55M public offering of common stock and warrants","bullets":["Sold 654,990 shares and warrants to purchase 196,497 shares at $3.90 per unit, including full over-allotment.","Gross proceeds of $2.55M; net proceeds for working capital and general corporate purposes.","Warrants exercisable immediately at $3.90/share, expire March 10, 2028.","Underwriter received Representative Warrants for 32,750 shares at $4.875/share, expiring March 8, 2028.","Common stock outstanding post-offering: 1,571,255 shares (assuming no warrant exercise)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-007271","json":"https://secwatch.observer/filing/0001493152-23-007271.json","markdown":"https://secwatch.observer/filing/0001493152-23-007271.md","text":"https://secwatch.observer/filing/0001493152-23-007271.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223007271/0001493152-23-007271-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223007271/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:38:51.919997+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3cb5973872a4f65a0e53c4489e59d21ab816cda9","claim":"INTELLIGENT BIO SOLUTIONS INC. entered into Underwriting Agreement with Ladenburg Thalmann & Co. Inc., as representative of the several underwriters valued at approximately $2.55 million (effective 2023-03-08).","evidence_excerpt":"On March 8, 2023, Intelligent Bio Solutions Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Ladenburg Thalmann & Co. Inc., as representatives (the “Representative”) of the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), relating to an underwritten public offering of 569,560 shares","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223007271/0001493152-23-007271-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Ladenburg Thalmann & Co. Inc., as representative of the several underwriters"},{"label":"Value","value":"approximately $2.55 million"},{"label":"Effective","value":"2023-03-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}